271 related articles for article (PubMed ID: 34699671)
1. Efficacy and Safety of tranexamic acid versus vitamin c after microneedling in treatment of melasma: Clinical and Dermoscopic study.
El Attar Y; Doghaim N; El Far N; El Hedody S; Hawwam SA
J Cosmet Dermatol; 2022 Jul; 21(7):2817-2825. PubMed ID: 34699671
[TBL] [Abstract][Full Text] [Related]
2. Randomized, double-blind, placebo-controlled split-face trial of the efficacy of tranexamic acid by drug delivery through microneedling in the treatment of melasma.
Kuster Kaminski Arida D; Orso Rebellato PR; Marioto de Campos GL; Costa A; Vilaverde Schmitt J; Larocca Skare T; Rodrigues Lisboa Faucz L
J Cosmet Dermatol; 2021 Dec; 20(12):4005-4010. PubMed ID: 34077619
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the effectiveness of microneedling with tranexamic acid in comparison with microneedling with vitamin C in the treatment of melasma: A prospective and single-blind clinical trial.
Pazyar N; Raeispour M; Yaghoobi R; Seyedtabib M
Health Sci Rep; 2023 Oct; 6(10):e1636. PubMed ID: 37867785
[TBL] [Abstract][Full Text] [Related]
4. Clinical Efficacy of Topical Tranexamic Acid With Microneedling in Melasma.
Kaur A; Bhalla M; Pal Thami G; Sandhu J
Dermatol Surg; 2020 Nov; 46(11):e96-e101. PubMed ID: 32769524
[TBL] [Abstract][Full Text] [Related]
5. The efficacy and safety of microneedling with topical tranexamic acid for melasma treatment: A systematic review and meta-analysis.
Feng X; Su H; Xie J
J Cosmet Dermatol; 2024 Jan; 23(1):33-43. PubMed ID: 37584240
[TBL] [Abstract][Full Text] [Related]
6. A Split Face Comparative Study of Safety and Efficacy of Microneedling with Tranexamic Acid versus Microneedling with Vitamin C in the Treatment of Melasma.
Menon A; Eram H; Kamath PR; Goel S; Babu AM
Indian Dermatol Online J; 2020; 11(1):41-45. PubMed ID: 32055507
[TBL] [Abstract][Full Text] [Related]
7. Dermoscopic evaluation of tranexamic acid versus Vitamin C, with microneedling in the treatment of melasma: a comparative, split-face, single-blinded study.
Tahoun AI; Mostafa WZ; Amer MA
J Dermatolog Treat; 2022 May; 33(3):1623-1629. PubMed ID: 33393842
[TBL] [Abstract][Full Text] [Related]
8. Tranexamic Acid for Melasma Treatment: A Split-Face Study.
Ebrahim HM; Said Abdelshafy A; Khattab F; Gharib K
Dermatol Surg; 2020 Nov; 46(11):e102-e107. PubMed ID: 32701529
[TBL] [Abstract][Full Text] [Related]
9. Microneedling with glutathione versus microneedling alone in treatment of facial melasma: Split-face comparative study.
Mohamed M; Beshay YMA; Assaf HM
J Cosmet Dermatol; 2023 Dec; 22(12):3379-3386. PubMed ID: 37313658
[TBL] [Abstract][Full Text] [Related]
10. Microneedling as an adjuvant to topical therapies for melasma: A systematic review and meta-analysis.
Bailey AJM; Li HO; Tan MG; Cheng W; Dover JS
J Am Acad Dermatol; 2022 Apr; 86(4):797-810. PubMed ID: 33857549
[TBL] [Abstract][Full Text] [Related]
11. Clinical, dermoscopic, and histopathologic evaluation of vitamin C versus PRP, with microneedling in the treatment of mixed melasma: A split-face, comparative study.
Abdel-Rahman AT; Abdel-Hakeem FG; Ragaie MH
Dermatol Ther; 2022 Feb; 35(2):e15239. PubMed ID: 34851010
[TBL] [Abstract][Full Text] [Related]
12. Microneedling-assisted topical tranexamic acid solution versus 4% hydroquinone for treating melasma: A split-face randomized study.
Zaky MS; Obaid ZM; Khalil EA; Elsaie ML
J Cosmet Dermatol; 2021 Dec; 20(12):4011-4016. PubMed ID: 34525492
[TBL] [Abstract][Full Text] [Related]
13. Assessment of combined fractional CO
Tawfic SO; Abdel Halim DM; Albarbary A; Abdelhady M
Lasers Surg Med; 2019 Jan; 51(1):27-33. PubMed ID: 30431171
[TBL] [Abstract][Full Text] [Related]
14. A split-face, investigator-blinded comparative study on the efficacy and safety of Q-switched Nd:YAG laser plus microneedling with vitamin C versus Q-switched Nd:YAG laser for the treatment of recalcitrant melasma.
Ustuner P; Balevi A; Ozdemir M
J Cosmet Laser Ther; 2017 Nov; 19(7):383-390. PubMed ID: 28657378
[TBL] [Abstract][Full Text] [Related]
15. Methimazole in the Treatment of Melasma: A Clinical and Dermascopic Study.
Farag A; Hammam M; Alnaidany N; Badr E; Elshaib M; El-Swah A; Shehata W
J Clin Aesthet Dermatol; 2021 Feb; 14(2):14-20. PubMed ID: 34221222
[No Abstract] [Full Text] [Related]
16. Histological changes in facial melasma after treatment with triple combination cream with or without oral tranexamic acid and/or microneedling: A randomised clinical trial.
Cassiano DP; Espósito ACC; Hassun KM; Lima MMDA; Lima EVA; Miot LDB; Miot HA; Bagatin E
Indian J Dermatol Venereol Leprol; 2022; 88(6):761-770. PubMed ID: 35389028
[TBL] [Abstract][Full Text] [Related]
17. Microneedling with cutaneous delivery of topical agents for the treatment of melasma: A systematic review.
Brasil Dos Santos J; Nagem Lopes LP; de Lima GG; Teixeira da Silva R; da Silva E Souza Lorca B; Miranda Pinheiro G; Faria de Freitas ZM
J Cosmet Dermatol; 2022 Nov; 21(11):5680-5695. PubMed ID: 35933690
[TBL] [Abstract][Full Text] [Related]
18. The efficacy and safety of topical tranexamic acid (liposomal or lotion with microneedling) versus conventional hydroquinone in the treatment of melasma.
Xing X; Chen L; Xu Z; Jin S; Zhang C; Xiang L
J Cosmet Dermatol; 2020 Dec; 19(12):3238-3244. PubMed ID: 33091202
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of microneedling plus topical 4% tranexamic acid solution vs 4% hydroquinone in the treatment of melasma: A single-blind randomized clinical trial.
Shamsi Meymandi S; Mozayyeni A; Shamsi Meymandi M; Aflatoonian M
J Cosmet Dermatol; 2020 Nov; 19(11):2906-2911. PubMed ID: 32406162
[TBL] [Abstract][Full Text] [Related]
20. Intradermal injection of tranexamic acid versus platelet-rich plasma in the treatment of melasma: a split-face comparative study.
Abd Elraouf IG; Obaid ZM; Fouda I
Arch Dermatol Res; 2023 Aug; 315(6):1763-1770. PubMed ID: 36856856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
